Molecular imaging and prostate cancer: unmet clinical needs and future perspectives Stefano FantiFrancesco Giammarile Editorial 29 September 2016 Pages: 421 - 422
The oncologists’ unmet clinical needs for imaging in advanced prostate cancer Aurelius OmlinJoachim MuellerSilke Gillessen Review Article 04 August 2016 Pages: 423 - 431
The urologist’s unmet clinical needs in prostate cancer Jochen WalzGeraldine PignotIsabelle Brenot-Rossi Review Article 28 July 2016 Pages: 433 - 438
Bone imaging in prostate cancer: the evolving roles of nuclear medicine and radiology Gary J. R. CookGurdip AzadAnwar R. Padhani Review Article Open access 20 July 2016 Pages: 439 - 447
PET imaging in prostate cancer, state of the art: a review of 18F-choline and 11C-choline PET/CT applications Paolo CastellucciFrancesco CeciStefano Fanti Review Article 29 July 2016 Pages: 449 - 456
PET imaging of urokinase-type plasminogen activator receptor (uPAR) in prostate cancer: current status and future perspectives Dorthe SkovgaardMorten PerssonAndreas Kjaer Review Article Open access 04 July 2016 Pages: 457 - 465
PET imaging in prostate cancer, future trends: PSMA ligands Wolfgang P. FendlerChristina BluemelKen Herrmann Review Article 30 June 2016 Pages: 467 - 472
PET/MRI and prostate cancer Morand PiertIssam El NaqaMaria Picchio Review Article 22 June 2016 Pages: 473 - 485
Future trends in prostate cancer theranostics with PSMA ligands Uwe HaberkornKlaus KopkaClemens Kratochwil Spotlight 14 July 2016 Pages: 487 - 489
Myocardial perfusion scintigraphy dosimetry: optimal use of SPECT and SPECT/CT technologies in stress-first imaging protocol M. LecchiS. MalaspinaA. Del Sole Review Article Open access 31 October 2016 Pages: 491 - 498
Erratum to: Role of intraoperative sentinel node imaging in head and neck cancer Clare SchillingAndrea Corrado ProfetaMark McGurk Erratum 22 September 2016 Pages: 499 - 499